CoChat

Dehydroepiandrosterone (DHEA): Hypes and Hopes

The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.

Abstract

Dehydroepiandrosterone (DHEA) and its sulfated form dehydroepiandrosterone sulfate (DHEAS) are the most abundant circulating steroid hormones in humans. In animal studies, their low levels have been associated with age-related involuntary changes, including reduced lifespan. Extrapolation of animal data to humans turned DHEA into a 'superhormone' and an 'anti-aging' panacea. It has been aggressively marketed and sold in large quantities as a dietary supplement. Recent double-blind, placebo-controlled human studies provided evidence to support some of these claims. In the elderly, DHEA exerts an immunomodulatory action, increasing the number of monocytes, T cells expressing T-cell receptor gamma/delta (TCRγδ) and natural killer (NK) cells. It improves physical and psychological well-being, muscle strength and bone density, and reduces body fat and age-related skin atrophy stimulating procollagen/sebum production. In adrenal insufficiency, DHEA restores DHEA/DHEAS and androstenedione levels, reduces total cholesterol, improves well-being, sexual satisfaction and insulin sensitivity, and prevents loss of bone mineral density. Normal levels of CD4+CD25(hi) and FoxP3 (forkhead box P3) are restored. In systemic lupus erythematosus, DHEA is steroid-sparing. In an unblinded study, it induced remission in the majority of patients with inflammatory bowel disease. DHEA modulates cardiovascular signalling pathways and exerts an anti-inflammatory, vasorelaxant and anti-remodelling effect. Its low levels correlate with increased cardiovascular disease and all-cause mortality. DHEA/DHEAS appear protective in asthma and allergy. It attenuates T helper 2 allergic inflammation, and reduces eosinophilia and airway hyperreactivity. Low levels of DHEAS accompany adrenal suppression. It could be used to screen for the side effects of steroids. In women, DHEA improves sexual satisfaction, fertility and age-related vaginal atrophy. Many factors are responsible for the inconsistent/negative results of some studies. Overreliance on animal models (DHEA is essentially a human molecule), different dosing protocols with non-pharmacological doses often unachievable in humans, rapid metabolism of DHEA, co-morbidities and organ-specific differences render data interpretation difficult. Nevertheless, a growing body of evidence supports the notion that DHEA is not just an overrated dietary supplement but a useful drug for some, but not all, human diseases. Large-scale randomised controlled trials are needed to fine-tune the indications and optimal dosing protocols before DHEA enters routine clinical practice.

Overview

Integrity signals

Registry

Crossref · 10.1007/s40265-014-0259-8

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 95 references

Research works printed but not linked: 2

  1. ChEBI: the database and ontology of Chemical Entities of Biological Interest. Dehydroepiandrosterone (CHEBI 28689). Available from http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5881 . Accessed 5 July 2014.
  2. ChEBI: the database and ontology of Chemical Entities of Biological Interest. Dehydroepiandrosterone sulfate (CHEBI 16814). Available from http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=12594&loc=ec_rcs . Accessed 5 July 2014.

Cited by

See all 216

Metadata

Authors
Rutkowski, K., Sowa, P., Rutkowska-Talipska, J., Kuryliszyn-Moskal, A., & Rutkowski, R.
Affiliations
  • Cambridge University Hospitals NHS Foundation Trust (GB)
  • Medical University of Białystok (PL)
Corresponding author
Rutkowski, Krzysztof
Venue
Drugs
Published
2014-07
Volume
74
Issue
11
Pages
1195-1207
ISSN
  • 0012-6667 (ISSN-L)
  • 1179-1950
OpenAlex
W1993292496
Cited by
216
References
95
Citations by year
2026: 16 · 2025: 21 · 2024: 21 · 2023: 18 · 2022: 20 · 2021: 21 · 2020: 18 · 2019: 15 · 2018: 28 · 2017: 14 · 2016: 14 · 2015: 9 · 2014: 1
FWCI
2.01
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Drugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
dehydroepiandrosterone, DHEA sulfate, anti-aging, dietary supplements, immunomodulation, adrenal insufficiency, systemic lupus erythematosus, inflammatory bowel disease, cardiovascular disease, asthma and allergy, vaginal atrophy, sexual satisfaction, animal-to-human extrapolation, DHEA metabolism, sex differences, adverse effects of steroids
MeSH terms
Adrenal Insufficiency, Aging, Animals, Dehydroepiandrosterone, Humans, Hypersensitivity, Bone Density, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dehydroepiandrosterone (DHEA): Hypes and Hopes. https://app.cochat.ai/papers/10.1007/s40265-014-0259-8
The paper
Rutkowski, K., Sowa, P., Rutkowska-Talipska, J., Kuryliszyn-Moskal, A., & Rutkowski, R. (2014). Dehydroepiandrosterone (DHEA): Hypes and Hopes. Drugs. https://doi.org/10.1007/s40265-014-0259-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.